BioPorto - Asset Resilience Ratio

Latest as of March 2022: 55.77%

BioPorto (BIOPOR) has an Asset Resilience Ratio of 55.77% as of March 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See BioPorto current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Dkr91.05 Million

≈ $14.24 Million USD Cash + Short-term Investments

Total Assets

Dkr163.26 Million

≈ $25.54 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (1999–1999)

This chart shows how BioPorto's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see BIOPOR current and non-current assets.

Liquid Assets Composition Over Time

This chart breaks down BioPorto's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read BioPorto (BIOPOR) total liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Dkr0.00	0%
Short-term Investments	Dkr91.05 Million	55.77%
Total Liquid Assets	Dkr91.05 Million	55.77%

Asset Resilience Insights

Very High Liquidity: BioPorto maintains exceptional liquid asset reserves at 55.77% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

BioPorto Industry Peers by Asset Resilience Ratio

Compare BioPorto's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
LONZA GROUP UNSP.ADR 1/10 F:LO3A	Diagnostics & Research	3.04%
Healius Ltd AU:HLS	Diagnostics & Research	0.06%
Eurofins-Cerep SA PA:ALECR	Diagnostics & Research	13.42%
Gencurix Inc KQ:229000	Diagnostics & Research	4.01%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%

Annual Asset Resilience Ratio for BioPorto (1999–1999)

The table below shows the annual Asset Resilience Ratio data for BioPorto.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
1999-12-31	0.51%	Dkr69.00K ≈ $10.80K	Dkr13.48 Million ≈ $2.11 Million	--

pp = percentage points

About BioPorto

CO:BIOPOR Denmark Diagnostics & Research

Market Cap

$85.98 Million

Dkr549.56 Million DKK

Market Cap Rank

#19855 Global

#87 in Denmark

Share Price

Dkr1.11

Change (1 day)

-0.45%

52-Week Range

Dkr0.84 - Dkr1.37

All Time High

Dkr7.78